G-ray Switzerland SA is a development stage company, based in the State of Neuchâtel, Switzerland, with validated core competencies in monolithic CMOS integrated pixel array detector technology.
Our mission is to deliver new solutions supporting the development of personal medicine through safer and better X-ray medical imaging. Our first product, the latenium™ detector, will deliver unprecedented price-performance ratio: we aim at establishing latenium™ as an industry-leading product together with established industry actors.
The company addresses a large unmet need for low dose X-ray medical applications and brings deep expertise in the areas of:
- compounds with ultra-high sensitivity
- direct (covalent) bonding technology and the epitaxial growth of defect-free silicon-germanium absorber structures on silicon.
We leverage the most recent technologies in material sciences, electronics and medical imaging to innovate and create long-term value for society and shareholders.
We want to be a global healthcare technology provider and cultivate an open corporate culture with high ethical standards. We promote innovation, transparency, quality, collaboration, and performance in our interactions with suppliers, partners, the medical community and society.
Finally, we also want our core technologies to bring benefits to the industrial sector, in particular in areas contributing to increased compliance and safety.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.